IDEXX Laboratories, Inc.  

(Public, NASDAQ:IDXX)   Watch this stock  
Find more results for IDXX
+1.03 (0.57%)
Feb 16 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 180.84 - 183.78
52 week 141.02 - 198.73
Open 181.13
Vol / Avg. 0.00/644,101.00
Mkt cap 15.92B
P/E 55.56
Div/yield     -
EPS 3.28
Shares 87.10M
Beta 0.58
Inst. own 92%
May 3, 2018
IDEXX Laboratories Inc Annual Shareholders Meeting (Estimated) - 1:00PM EDT - Add to calendar
Apr 26, 2018
Q1 2018 IDEXX Laboratories Inc Earnings Release (Estimated) - 9:30AM EDT - Add to calendar
Mar 5, 2018
IDEXX Laboratories Inc at Raymond James Institutional Investors Conference - 4:00PM EST - Add to calendar
Feb 26, 2018
IDEXX Laboratories Inc at Bank of America Merrill Lynch Animal Health Summit - 1:25PM EST - Add to calendar
Feb 1, 2018
Q4 2017 IDEXX Laboratories Inc Earnings Release
Jan 10, 2018
IDEXX Laboratories Inc at JPMorgan Healthcare Conference - Webcast
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '17) 2017
Net profit margin 13.69% 14.94%
Operating margin 19.33% 20.98%
EBITD margin - 25.20%
Return on average assets 16.43% 18.14%
Return on average equity - -
Employees 7,600 -
CDP Score - -


1 Idexx Dr
WESTBROOK, ME 04092-2041
United States - Map
+1-207-5560300 (Phone)
+1-207-5564346 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


IDEXX Laboratories, Inc. develops, manufactures and distributes products and provides services for the companion animal veterinary, livestock and poultry, dairy and water testing markets. The Company also sells a line of portable electrolytes and blood gas analyzers for the human point-of-care medical diagnostics market. Its segments include diagnostic and information technology-based products and services for the veterinary market, which the Company refers to as the Companion Animal Group; water quality products; diagnostic products and services for livestock and poultry health, which the Company refers to as Livestock, Poultry and Dairy, and Other operating segment, which combines and presents products for the human point-of-care medical diagnostics market with its pharmaceutical product line and its out-licensing arrangements. Its products and services include point-of-care veterinary diagnostic products, comprising instruments, consumables and rapid assay test kits, among others.

Officers and directors

Jonathan W. Ayers Chairman of the Board, President, Chief Executive Officer
Age: 60
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Brian P. McKeon Chief Financial Officer, Executive Vice President, Treasurer
Age: 54
Bio & Compensation  - Reuters
Giovani Twigge Chief Human Resource Officer, Corporate Vice President
Age: 53
Bio & Compensation  - Reuters
Jay Mazelsky Executive Vice President
Age: 56
Bio & Compensation  - Reuters
Jacqueline L. Studer Corporate Vice President, General Counsel, Corporate Secretary
Age: 58
Bio & Compensation  - Reuters
William T. End Lead Independent Director
Age: 69
Bio & Compensation  - Reuters
Bruce L Claflin Independent Director
Age: 65
Bio & Compensation  - Reuters
Stuart M. Essig Ph.D. Independent Director
Age: 55
Bio & Compensation  - Reuters
Rebecca M. Henderson Ph.D. Independent Director
Age: 56
Bio & Compensation  - Reuters
Daniel M. Junius Independent Director
Age: 64
Bio & Compensation  - Reuters